BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 903037)

  • 1. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB; Baumel IP; Mattson RH; Woodbury SG
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antiepileptic blood levels in the treatment of patients with epilepsy.
    Fincham RW; Schottelius DD
    J Iowa Med Soc; 1973 Sep; 63(9):433-6. PubMed ID: 4742131
    [No Abstract]   [Full Text] [Related]  

  • 8. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses.
    Wilson JT; Wilkinson GR
    Neurology; 1974 Jul; 24(7):614-23. PubMed ID: 4858085
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.
    Kupferberg HJ
    Clin Chim Acta; 1970 Aug; 29(2):282-8. PubMed ID: 5493185
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A
    Fortschr Med; 1974 Oct; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG; Johnson RH
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):148-51. PubMed ID: 7217971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigations of serum levels of drugs in children receiving anticonvulsant medication. I. General evaluation of serum concentrations of diphenylhydantoin, primidone and phenobarbitone (author's transl)].
    Windorfer A; Gädeke R; Sauer M
    Z Kinderheilkd; 1975; 119(1):15-24. PubMed ID: 1124582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
    Lambie DG; Johnson RH; Nanda RN; Shakir RA
    Lancet; 1976 Aug; 2(7982):386-9. PubMed ID: 73851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulins in epilepsy.
    Slavin BN; Fenton GM; Laundy M; Reynolds EH
    J Neurol Sci; 1974 Nov; 23(3):353-7. PubMed ID: 4427121
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of diphenylhydantoin on primidone metabolism.
    Fincham RW; Schottelius DD; Sahs AL
    Arch Neurol; 1974 Mar; 30(3):259-62. PubMed ID: 4812960
    [No Abstract]   [Full Text] [Related]  

  • 18. Disappearance of phenobarbital and diphenylhydantoin from serum of children.
    Garrettson LK; Dayton PG
    Clin Pharmacol Ther; 1970; 11(5):674-9. PubMed ID: 5455632
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in response to anticonvulsants in a group of epileptic patients.
    Travers RD; Gallagher BB; Glaser GH
    Trans Am Neurol Assoc; 1971; 96():110-2. PubMed ID: 5159062
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
    Windorfer A; Sauer W; Gädeke R
    Acta Paediatr Scand; 1975 Sep; 64(5):771-2. PubMed ID: 1101639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.